Accustem Sciences INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OQB
AccuStem Sciences, Inc. filed its annual report for the fiscal year ended December 31, 2025, detailing continued net losses and significant cash burn, raising substantial doubt about its ability to continue as a going concern.
OQB
AccuStem Sciences outlines its plans to commercialize its MSC and StemPrintER diagnostic tests while reporting a net loss for the year ended December 31, 2024.
OQB
AccuStem Sciences Inc.'s 2023 annual report highlights the company's focus on commercializing its StemPrintER test while navigating financial losses and the need for additional funding.